Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a post hoc analysis of ORAL Surveillance

Riccardi V, Viscomi CF, Sandri M, D'Alessandro A, Dzieciatkowska M, Stephenson D, Federti E, Hermann A, Salviati L, Siciliano A, Andolfo I, Alper SL, Ceolan[...]

Chotard M, Wang X, Zheng X, Kaye TG, Grosmougin M, Barlow L, Kundrát M, Dececchi TA, Habib MB, Zariwala J, Hartman S, Xu X, Pittman[...]

Klein R, Julian KA, Alba-Nguyen S, Ufere NN, Jassal SK, Simon W, Millard A, Uthlaut B, Koch J, Snyder ED, Volerman A, Thompson V, Kumar[...]